131 results on '"Boursier, Jerome"'
Search Results
2. MASLD-related HCC: Multicenter study comparing patients with and without cirrhosis
3. Agile scores in MASLD and ALD: External validation and their utility in clinical algorithms
4. Food perception induces fast fragmentation of hepatic mitochondria
5. An international multidisciplinary consensus statement on MAFLD and the risk of CVD
6. Primary hypocholesterolemia is associated with an increased risk of hepatic complications in the general population
7. Prevalence of Liver Steatosis and Fibrosis in Adults With Primary Hypobetaliproteinemia: Results From the HYPOCHOL Study
8. A multisociety Delphi consensus statement on new fatty liver disease nomenclature
9. A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures
10. Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
11. A multisociety Delphi consensus statement on new fatty liver disease nomenclature
12. Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol
13. Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: An International Study With 1924 Patients
14. Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis
15. Associations between perfluoroalkyl substances and the severity of non-alcoholic fatty liver disease
16. A global research priority agenda to advance public health responses to fatty liver disease
17. Extracellular vesicles are carriers of adiponectin with insulin-sensitizing and anti-inflammatory properties
18. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis
19. Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study
20. Voies thérapeutiques dans l’hépatopathie stéatosique métabolique
21. Impact of Type 2 Diabetes on the Accuracy of Noninvasive Tests of Liver Fibrosis With Resulting Clinical Implications
22. Enhanced diagnosis of advanced fibrosis and cirrhosis in individuals with NAFLD using FibroScan-based Agile scores
23. Comorbidities Are Associated with Fibrosis in NAFLD Subjects: A Nationwide Study (NASH-CO Study)
24. Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance
25. Reliability Criteria of Two-Dimensional Shear Wave Elastography: Analysis of 4277 Measurements in 788 Patients
26. Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study
27. acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study
28. Management of diabetes mellitus in patients with cirrhosis: An overview and joint statement
29. LPS-enriched small extracellular vesicles from metabolic syndrome patients trigger endothelial dysfunction by activation of TLR4
30. Case-finding strategies in non-alcoholic fatty liver disease
31. Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver Disease
32. Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment
33. Obstructive sleep apnea, chronic obstructive pulmonary disease and NAFLD: an individual participant data meta-analysis
34. A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study
35. Hospitalization costs and risk of mortality in adults with nonalcoholic steatohepatitis: Analysis of a French national hospital database
36. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
37. FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
38. Development and Validation of Hepamet Fibrosis Scoring System–A Simple, Noninvasive Test to Identify Patients With Nonalcoholic Fatty Liver Disease With Advanced Fibrosis
39. New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD
40. Criteria to Determine Reliability of Noninvasive Assessment of Liver Fibrosis With Virtual Touch Quantification
41. Circulating PCSK9 levels are not associated with the severity of hepatic steatosis and NASH in a high-risk population
42. Phase 2, open-label, rollover study of cenicriviroc for liver fibrosis associated with metabolic dysfunction–associated steatohepatitis.
43. Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis
44. Association Between Severity of Obstructive Sleep Apnea and Blood Markers of Liver Injury
45. Nonalcoholic Fatty Liver Disease and the Gut Microbiome
46. Liver Stiffness Measurement With FibroScan: Use the Right Probe in the Right Conditions!
47. The NAFLD burden on mortality and morbidities in general population: A community‐based longitudinal study (NASH‐CO study).
48. Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests.
49. Screening for significant chronic liver disease by using three simple ultrasound parameters
50. Quantification of portal–bridging fibrosis area more accurately reflects fibrosis stage and liver stiffness than whole fibrosis or perisinusoidal fibrosis areas in chronic hepatitis C
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.